Welcome to our dedicated page for Hamilton Lane news (Ticker: HLNE), a resource for investors and traders seeking the latest updates and insights on Hamilton Lane stock.
Hamilton Lane Incorporated reports developments tied to its private markets investment platform, which provides investment solutions for institutional and private wealth clients. Company news commonly covers earnings releases, private credit and private infrastructure products, interval fund structures, capital-structure actions, and funds managed by Hamilton Lane participating in private equity, renewable infrastructure, and continuation-vehicle transactions.
Updates also include senior promotions across investment and client functions and product-access initiatives such as daily NAV pricing, quarterly repurchase features, and tokenized access where offered through specific fund structures.
Cosette Pharmaceuticals (HLNE) appointed David Bell as Chief Commercial Officer (Brands), joining the executive leadership team.
He will oversee all branded commercial functions, drive performance across 21 marketed brands, support integration of acquired assets, and align commercial execution with Cosette’s strategic and financial objectives.
MidOcean Partners closed a single-asset continuation vehicle for Cloyes (automotive timing-drive systems), securing approximately $300 million in commitments with Hamilton Lane (Nasdaq: HLNE) as sole lead investor. MidOcean made an additional investment and will retain a controlling stake; CEO John Hanighen was named Chairman.
The transaction funds Cloyes’ growth plans, supports acquisitions, and gives existing investors optional liquidity while extending MidOcean’s partnership with the company.
Cosette Pharmaceuticals (NASDAQ:HLNE) appointed Erika Tooman as Senior Vice President, General Counsel effective April 29, 2026. Tooman will oversee legal, compliance, governance, and risk management as Cosette scales its platform following recent acquisitions and continued growth initiatives. She joins from Radius Health and holds a JD, an MS in Biotechnology, and a BA in Biology.
The hire is presented as support for the company’s business development, M&A integration, and governance as Cosette pursues portfolio expansion and strategic partnerships.
Power Sustainable completed the sale of a 49.9% interest in Big Sky Wind (240 MW) to funds managed by Hamilton Lane and GCM Grosvenor on April 29, 2026. PSEI retains a majority stake and will continue to operate the fully repowered (2022) PJM-market asset while recycling capital for new investments.
This partnership with institutional investors supports PSEI's capital-recycling strategy and aims to scale its renewable infrastructure platform.
Hamilton Lane (Nasdaq: HLNE) will report fourth fiscal quarter and full fiscal year results for the period ended March 31, 2026 on May 21, 2026 before the market opens. A webcasted conference call will follow at 11:00 a.m. ET and replay will be available for one year.
The firm reported $1.0 trillion in assets under management and supervision, including $146.1 billion discretionary and $871.5 billion non-discretionary as of December 31, 2025.
Hamilton Lane (Nasdaq: HLNE) launched the Hamilton Lane Credit Income Fund (HLCIF) and converted the Hamilton Lane Private Infrastructure Fund (HLPIF) to interval fund structures on April 22, 2026. Both offer 1099 reporting, daily NAV, quarterly limited liquidity and minimums as low as $2,500 in certain share classes. HLCIF has > $350 million in commitments; HLPIF adds a tokenized access option via Republic and continues a co‑investment and secondaries infrastructure strategy.
Hamilton Lane (Nasdaq: HLNE) announced more than 25 senior promotions and appointments effective April 1, 2026, across Investment, Client Solutions, Portfolio Management, Legal, Finance and Operations.
The firm named multiple Managing Directors and Principals, added senior hires in U.S. sales and European direct credit, and highlighted service to over 2,600 institutional and private wealth investors and recent industry awards.
Cosette Pharmaceuticals closed an agreement to acquire U.S. sales and distribution rights for seven branded products from Assertio (Nasdaq: ASRT), adding a portfolio with $48.9 million in 2025 net sales. The deal includes SYMPAZAN® oral film, which establishes a Neurology rare disease footprint and carries patent protection through 2040.
The portfolio also includes INDOCIN®, SPRIX®, ZIPSOR®, CAMBIA®, and OTREXUP® (OTREXUP was discontinued in Aug 2025). A transition period will move manufacturing, supply, quality, pharmacovigilance, and regulatory responsibilities to Cosette.
Vero Fiber (HLNE) expanded its committed credit facility to $425 million, with an accordion to $585 million, to fund FTTP and dark fiber network expansion and support the acquisition of Telephone Electronics Corporation (TEC).
The facility replaces a prior $310 million credit line and was arranged by Hancock Whitney Bank, Texas Capital and J.P. Morgan, with increased commitments from existing lenders. Vero now serves 334 markets in 25 states.
Hamilton Lane (Nasdaq: HLNE) announced the SEC declared effective its first interval fund, the Hamilton Lane Credit Income Fund (HLCIF), on March 24, 2026. The fund offers 1099 tax reporting, quarterly repurchase offers, daily NAV pricing and competitive fees.
HLCIF targets middle‑market senior loans sourced via Hamilton Lane's multi‑manager private credit platform, which the company says totals $94 billion. HLCIF will join the firm's Evergreen Platform as its 12th fund; Hamilton Lane expects availability in April 2026.